Literature DB >> 5008233

Suppression of growth hormone-dependent human serum sulfation factor by estrogen.

E Wiedemann, E Schwartz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5008233     DOI: 10.1210/jcem-34-1-51

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  9 in total

1.  Editorial: Excessive height.

Authors: 
Journal:  Br Med J       Date:  1975-06-21

Review 2.  Interactive regulation of postmenopausal growth hormone insulin-like growth factor axis by estrogen and growth hormone-releasing peptide-2.

Authors:  J D Veldhuis; W S Evans; C Y Bowers; S Anderson
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.633

3.  Untreated hypopituitarism due to absence of the pituitary stalk with normal adult height: report of two cases.

Authors:  Leda Papastathopoulou; Marinella Tzanela; Vania Vlassopoulou; Dimitra Vassiliadi; Nikolaos Thalassinos
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

4.  Effect of different oestrogen doses on final height reduction in girls with constitutional tall stature.

Authors:  A Grüters; P Heidemann; H Schlüter; P Stubbe; B Weber; H Helge
Journal:  Eur J Pediatr       Date:  1989-10       Impact factor: 3.183

Review 5.  Estrogens and selective estrogen receptor modulators in acromegaly.

Authors:  Felipe H Duarte; Raquel S Jallad; Marcello D Bronstein
Journal:  Endocrine       Date:  2016-10-04       Impact factor: 3.633

Review 6.  Estrogen treatment for acromegaly.

Authors:  Ilan Shimon; Ariel Barkan
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

Review 7.  Biochemical investigations in diagnosis and follow up of acromegaly.

Authors:  Katharina Schilbach; Christian J Strasburger; Martin Bidlingmaier
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

Review 8.  Acromegaly update--etiology, diagnosis and management.

Authors:  S Melmed; J A Fagin
Journal:  West J Med       Date:  1987-03

9.  Polycystic ovarian disease: endocrinological parameters with specific reference to growth hormone and somatomedin-C.

Authors:  W Urdl
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.